A Phase 1 Study to Assess the Effects in the Body of a Single Dose of Trientine Dihydrochloride in Wilson's Disease Patients

NCT01874028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Wilson's Disease

Interventions

DRUG: trientine dihydrochloride

Sponsor

Univar BV

Collaborators

[object Object]